Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -477.54% is 37% below its 5-year average of -349.22%, around the middle of its 5-year range (-783.41%–-86.96%).
As of the fiscal period ended Tuesday, June 30, 2026. 9.94% below its 12-month average of -434.35%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -477.54%.
RETURN ON EQUITY (ROE)
-477.54%
RETURN ON EQUITY (ROE) AVG TTM
-434.35%
RETURN ON EQUITY (ROE) AVG 3Y
-484.98%
RETURN ON EQUITY (ROE) AVG 5Y
-349.22%
RETURN ON EQUITY (ROE) AVG 10Y
-260.62%
RETURN ON EQUITY (ROE) AVG 15Y
-299.22%
RETURN ON EQUITY (ROE) AVG 20Y
-301.01%
CURRENT VS TTM AVG
-9.94%
CURRENT VS 3Y AVG
+1.53%
CURRENT VS 5Y AVG
-36.74%
CURRENT VS 10Y AVG
-83.23%
CURRENT VS 15Y AVG
-59.59%
CURRENT VS 20Y AVG
-58.64%
SECTOR MEDIAN · HEALTHCARE
-40.76%
median of 687 covered companies
CURRENT VS SECTOR MEDIAN
-1071.59%
vs the sector median at left
Cerenome, Inc.
Market Cap
$10.88M
Return on Equity (ROE)
-477.54%
TTM Avg
-434.35%
3Y Avg
-484.98%
5Y Avg
-349.22%
Market Cap
$10.96M
Return on Equity (ROE)
-506.63%
TTM Avg
-300.20%
3Y Avg
-300.20%
5Y Avg
-300.20%
Market Cap
$11.24M
Return on Equity (ROE)
-37052.06%
TTM Avg
-237.80%
3Y Avg
-258.91%
5Y Avg
-310.30%
Market Cap
$11.12M
Return on Equity (ROE)
-65.18%
TTM Avg
-26.62%
3Y Avg
-94.28%
5Y Avg
-90.35%
Market Cap
$11.12M
Return on Equity (ROE)
-214.92%
TTM Avg
-46.13%
3Y Avg
-156.76%
5Y Avg
-652.77%
Market Cap
$10.65M
Return on Equity (ROE)
-177.35%
TTM Avg
-89.62%
3Y Avg
-75.99%
5Y Avg
-59.80%
Market Cap
$11.27M
Return on Equity (ROE)
N/A
TTM Avg
216.74%
3Y Avg
-5384.23%
5Y Avg
-3626.91%
Market Cap
$10.55M
Return on Equity (ROE)
-252.37%
TTM Avg
-195.20%
3Y Avg
-116.68%
5Y Avg
-90.09%
Market Cap
$10.51M
Return on Equity (ROE)
N/A
TTM Avg
-43.97%
3Y Avg
-160.70%
5Y Avg
-188.29%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cerenome, Inc. (CNSY) | $10.88M | -477.54% | -434.35% | -484.98% | -349.22% |
| Caring Brands, Inc. (CABR)vs › | $10.96M | -506.63% | -300.20% | -300.20% | -300.20% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.24M | -37052.06% | -237.80% | -258.91% | -310.30% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | -65.18% | -26.62% | -94.28% | -90.35% |
| BioVie Inc. (BIVI)vs › | $11.12M | -214.92% | -46.13% | -156.76% | -652.77% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.65M | -177.35% | -89.62% | -75.99% | -59.80% |
| Pluri Inc. (PLUR)vs › | $11.27M | N/A | 216.74% | -5384.23% | -3626.91% |
| Lifeward Ltd. (LFWD)vs › | $10.55M | -252.37% | -195.20% | -116.68% | -90.09% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.51M | N/A | -43.97% | -160.70% | -188.29% |
| Biofrontera Inc. (BFRI)vs › | $11.39M | -106.87% | -250.57% | -230.96% | -240.83% |
ROE
-477.5%
ROA
-185.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -477.54% |
| 2026-03-31 | -99.75% |
| 2025-12-31 | -560.21% |
| 2025-09-30 | -407.12% |
| 2025-06-30 | -627.13% |
| 2023-09-30 | -578.34% |
| 2023-06-30 | -644.78% |
| 2023-03-31 | -783.41% |
| 2022-12-31 | -314.58% |
| 2022-09-30 | -164.61% |
| 2022-06-30 | -178.50% |
| 2022-03-31 | -101.04% |
| 2021-12-31 | -123.65% |
| 2021-09-30 | -86.96% |
| 2021-06-30 | -90.71% |
| 2021-03-31 | -103.79% |
| 2020-12-31 | -271.89% |
| 2020-09-30 | -143.84% |
| 2020-06-30 | -45.94% |
| 2019-12-31 | -938.53% |
| 2019-03-31 | -294.92% |
| 2018-12-31 | -241.80% |
| 2018-09-30 | -239.25% |
| 2018-06-30 | -361.23% |
| 2018-03-31 | -230.57% |
| 2017-12-31 | -174.52% |
| 2017-09-30 | -298.24% |
| 2017-06-30 | -212.79% |
| 2017-03-31 | -329.38% |
| 2016-12-31 | -200.68% |
| 2016-09-30 | -145.51% |
| 2016-06-30 | -69.33% |
| 2016-03-31 | -27.44% |
| 2015-12-31 | -153.56% |
| 2015-09-30 | -434.74% |
| 2013-12-31 | -835.76% |
| 2012-12-31 | -500.08% |
| 2012-03-31 | -433.65% |
| 2011-12-31 | -326.28% |
| 2011-09-30 | -291.77% |
| 2011-06-30 | -363.65% |
| 2011-03-31 | -300.40% |
| 2010-12-31 | -120.19% |
| 2010-09-30 | -613.77% |
| 2010-06-30 | -171.03% |
| 2010-03-31 | -153.59% |
| 2007-06-30 | -518.76% |
| 2005-09-30 | -385.10% |
| 2005-06-30 | -159.81% |
| 2005-03-31 | -97.59% |
| 2004-12-31 | -16.29% |
| 2004-09-30 | 6.30% |
| 2004-06-30 | -49.65% |
| 2004-03-31 | -27.53% |
| 2003-12-31 | -62.26% |
| 2003-09-30 | -71.90% |
| 2003-06-30 | -66.37% |
